Neurocritical Care
Microcirculatory ischemia
Protein catabolism in severe critical illness/immobility may cause muscle wasting.
Sepsis
Multiorgan dysfunction
Hyperglycemia
| d. | Renal failure |
|---|
Neuromuscular blockade
Duration of vasopressor or corticosteroid therapy
Duration of ICU stay
Limb and diaphragm weakness may persist for weeks to months.
or breathe.
No specific treatments have been shown effective.
Intensive glycemic control may reduce critical illness neuropathy.
Passive mobilization/early physical therapy in the ICU
Daily awakening/less time on the ventilator
Limiting risk factors as much as possible
1.11 cases per 100,000 person-years
Bilateral symmetric progressive weakness of limbs
Nerve conduction studies may provide a more precise diagnosis.
Typically associated with Campylobacter jejuni infection. Also associated with Epstein-Barr virus,
varicella-zoster, and Mycoplasma pneumoniae infections
has not been associated with other seasonal influenza vaccines.
Progressive weakness over 3–4 weeks
Mortality rate around 5%